A detailed history of Brookstone Capital Management transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Brookstone Capital Management holds 2,558 shares of TMO stock, worth $1.34 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,558
Previous 2,482 3.06%
Holding current value
$1.34 Million
Previous $1.37 Million 15.31%
% of portfolio
0.03%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$531.86 - $624.21 $40,421 - $47,439
76 Added 3.06%
2,558 $1.58 Million
Q2 2024

Jul 18, 2024

SELL
$541.52 - $599.02 $1.03 Million - $1.14 Million
-1,905 Reduced 43.42%
2,482 $1.37 Million
Q1 2024

Apr 15, 2024

BUY
$528.82 - $599.43 $1.66 Million - $1.88 Million
3,142 Added 252.37%
4,387 $2.55 Million
Q4 2023

Jan 11, 2024

SELL
$431.41 - $532.94 $781,714 - $965,687
-1,812 Reduced 59.27%
1,245 $660,000
Q3 2023

Oct 20, 2023

SELL
$498.29 - $574.41 $310,932 - $358,431
-624 Reduced 16.95%
3,057 $1.55 Million
Q2 2023

Jul 11, 2023

BUY
$508.46 - $591.13 $95,082 - $110,541
187 Added 5.35%
3,681 $1.92 Million
Q1 2023

Apr 18, 2023

SELL
$535.0 - $604.82 $81,855 - $92,537
-153 Reduced 4.2%
3,494 $2.01 Million
Q4 2022

Jan 09, 2023

SELL
$484.71 - $571.37 $132,810 - $156,555
-274 Reduced 6.99%
3,647 $0
Q3 2022

Oct 13, 2022

BUY
$507.19 - $604.49 $60,862 - $72,538
120 Added 3.16%
3,921 $1.96 Million
Q2 2022

Jul 11, 2022

SELL
$500.9 - $612.21 $185,333 - $226,517
-370 Reduced 8.87%
3,801 $2.11 Million
Q1 2022

Apr 12, 2022

SELL
$524.0 - $644.92 $214,316 - $263,772
-409 Reduced 8.93%
4,171 $2.44 Million
Q4 2021

Jan 11, 2022

BUY
$569.0 - $667.24 $139,405 - $163,473
245 Added 5.65%
4,580 $2.78 Million
Q3 2021

Nov 03, 2021

BUY
$509.53 - $609.78 $76,939 - $92,076
151 Added 3.61%
4,335 $2.49 Million
Q2 2021

Jul 14, 2021

BUY
$441.0 - $508.24 $1.13 Million - $1.3 Million
2,554 Added 156.69%
4,184 $2.15 Million
Q1 2021

Apr 16, 2021

SELL
$439.85 - $518.83 $280,624 - $331,013
-638 Reduced 28.13%
1,630 $744,000
Q4 2020

Jan 13, 2021

SELL
$435.06 - $527.66 $107,894 - $130,859
-248 Reduced 9.86%
2,268 $1.06 Million
Q3 2020

Oct 13, 2020

BUY
$359.77 - $441.52 $207,947 - $255,198
578 Added 29.82%
2,516 $1.11 Million
Q2 2020

Jul 21, 2020

BUY
$275.2 - $362.34 $283,456 - $373,210
1,030 Added 113.44%
1,938 $702,000
Q1 2020

Apr 14, 2020

SELL
$255.3 - $340.05 $92,673 - $123,438
-363 Reduced 28.56%
908 $258,000
Q4 2019

Jan 29, 2020

BUY
$271.93 - $328.04 $45,412 - $54,782
167 Added 15.13%
1,271 $413,000
Q3 2019

Oct 18, 2019

SELL
$268.46 - $305.43 $1,073 - $1,221
-4 Reduced 0.36%
1,104 $322,000
Q2 2019

Jul 25, 2019

SELL
$257.51 - $295.55 $35,021 - $40,194
-136 Reduced 10.93%
1,108 $325,000
Q1 2019

Apr 18, 2019

BUY
$212.17 - $273.72 $263,939 - $340,507
1,244 New
1,244 $341,000
Q4 2018

Feb 06, 2019

SELL
$208.47 - $251.98 $173,238 - $209,395
-831 Closed
0 $0
Q3 2018

Nov 05, 2018

BUY
$205.57 - $244.32 $170,828 - $203,029
831 New
831 $203,000
Q2 2018

Aug 06, 2018

SELL
$203.14 - $219.53 $198,061 - $214,041
-975 Closed
0 $0
Q1 2018

Apr 23, 2018

BUY
$192.98 - $224.11 $188,155 - $218,507
975 New
975 $201,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $205B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Brookstone Capital Management Portfolio

Follow Brookstone Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.